Viewing Study NCT04657094


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-27 @ 11:09 PM
Study NCT ID: NCT04657094
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-27
First Post: 2020-12-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia
Sponsor: City of Hope Medical Center
Organization: